Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

NCT04461886 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.

NCT NCT04461886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04461886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I
Lead sponsor
Nobelpharma
Phase
Phase 3
Overall status
Terminated
Start date
July 8, 2020
Completion date
December 7, 2021
Enrollment
100 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis